- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 19.59M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 19.58M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 12.9M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $19.97M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $0 |
| Capex | Q1 2026 · Mar 31, 2026 | $1.27M |
| Capex | Q1 2026 · Mar 31, 2025 | $108K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $6.79M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $68.09M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $2.48M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $18.12M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $171.18M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $203.9M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $335.48M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $337.02M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $186.06M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $162.39M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $839.57M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $888.05M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.18B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.23B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.02 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $2.78 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.02 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $2.78 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $15.97M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $5.01M |
| Net Income | Q1 2026 · Mar 31, 2026 | $19.91M |
| Net Income | Q1 2026 · Mar 31, 2025 | $38.1M |
| Revenue | Q1 2026 · Mar 31, 2026 | $90.93M |
| Revenue | Q1 2026 · Mar 31, 2025 | $71.89M |